Main outcome parameters and results: The main efficacy parameter was the effect of treatment on 6- and 12-month changes from baseline in nerve conduction velocity (NCV) and amplitude in the sensory (ulnar, sural and median) and motor (median, ulnar and peroneal) nerves
Precautions Keep out reach of children
You should never inject medication that is not perfectly transparent
In controlled research environments, it is utilised as a model compound in studies involving IGF-related pathways, peptide structure, and receptor interaction systems
The better treatment option will depend on different factors like the patients age and overall condition
To view a copy of this licence, visit About this article Cite this article Szkudlarek, H.J., Singh Mann, R., Wieczerzak, K